Cargando…
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)
BACKGROUND: The COVID-19 outbreak challenges the Spanish health system since March 2020. Some available therapies (antimalarials, antivirals, biological agents) were grounded on clinical case observations or basic science data. The aim of this study is to describe the characteristics and impact of d...
Ejemplares similares
-
Cyclosporine A and COVID19 – The COQUIMA cohort – Author's reply
por: Guisado-Vasco, Pablo, et al.
Publicado: (2020) -
Cyclosporine A and COVID-19 – The COQUIMA cohort
por: Schuurmans, Macé M., et al.
Publicado: (2020) -
Cyclosporine A and COVID19 – The COQUIMA cohort
por: Sánchez-Pernaute, Olga
Publicado: (2020) -
Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
por: Echave-Sustaeta, Jose M, et al.
Publicado: (2014) -
Stress, subjective wellbeing and self-knowledge in higher education teachers: A pilot study through bodyfulness approaches
por: Rodríguez-Jiménez, Rosa-María, et al.
Publicado: (2022)